ARTICLE | Editor's Commentary
The ladder into biopharma is getting pulled up behind us, it’s time to reach down: a Perspective
Academic funding cuts are removing the on-ramps into biopharma. How can industry help ensure the next generation of talent finds a way in?
June 24, 2025 11:56 PM UTC
We all have an origin story about the experiences that brought us to the biopharma industry, usually including time spent in academic research labs. For new generations, such opportunities are poised to become increasingly out of reach.
Whether via a full Ph.D.-plus-postdoc journey, a master’s thesis, an undergraduate internship, a high school program, or a tech or lab manager role, academic labs have long been the most accessible portal into the biomedical innovation ecosystem. ...